Trials / Completed
CompletedNCT04763070
Ciprofloxacin in Drug-resistant Epilepsy
Effect of Ciprofloxacin on Seizure Frequency in Patients With Drug-resistant Epilepsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Mazandaran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 16 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the effect of a short-term prescription of ciprofloxacin on intestinal microbial pattern and seizure frequency of patients with drug-resistant epilepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ciprofloxacin Oral Product | The first stool sample will be taken before treatment and the second one will be taken in day 5 to 7 after treatment initiation. Treatment includes ciprofloxacin tablet 500mg twice a day for 5 days. |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-04-01
- Completion
- 2021-06-01
- First posted
- 2021-02-21
- Last updated
- 2021-06-07
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT04763070. Inclusion in this directory is not an endorsement.